149 related articles for article (PubMed ID: 15950572)
1. Success, safety, and mechanisms of failure of percutaneous coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery total occlusion.
Abbas AE; Brewington SD; Dixon SR; Boura J; Grines CL; O'Neill WW
Am J Cardiol; 2005 Jun; 95(12):1462-6. PubMed ID: 15950572
[TBL] [Abstract][Full Text] [Related]
2. Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
Abizaid A; Popma JJ; Tanajura LF; Hattori K; Solberg B; Larracas C; Feres F; Costa Jde R; Schwartz LB
Catheter Cardiovasc Interv; 2007 Dec; 70(7):914-9. PubMed ID: 18044791
[TBL] [Abstract][Full Text] [Related]
3. Use of the Stingray guidewire and the Venture catheter for crossing flush coronary chronic total occlusions due to in-stent restenosis.
Brilakis ES; Lombardi WB; Banerjee S
Catheter Cardiovasc Interv; 2010 Sep; 76(3):391-4. PubMed ID: 20839355
[TBL] [Abstract][Full Text] [Related]
4. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
[TBL] [Abstract][Full Text] [Related]
6. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
[TBL] [Abstract][Full Text] [Related]
8. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
Chevalier B; Di Mario C; Neumann FJ; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB;
JACC Cardiovasc Interv; 2008 Oct; 1(5):524-32. PubMed ID: 19463354
[TBL] [Abstract][Full Text] [Related]
10. Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions.
Fonseca A; Costa Jde R; Abizaid A; Feres F; Abizaid AS; Costa R; Staico R; Mattos LA; Sousa AG; Grube E; Sousa JE
J Invasive Cardiol; 2008 Jan; 20(1):21-7. PubMed ID: 18174614
[TBL] [Abstract][Full Text] [Related]
11. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
13. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
Shaikh F; Maddikunta R; Djelmami-Hani M; Solis J; Allaqaband S; Bajwa T
Catheter Cardiovasc Interv; 2008 Apr; 71(5):614-8. PubMed ID: 18360853
[TBL] [Abstract][Full Text] [Related]
14. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855
[TBL] [Abstract][Full Text] [Related]
16. Management of total restenotic occlusions.
Werner GS; Moehlis H; Tischer K
EuroIntervention; 2009 May; 5 Suppl D():D79-83. PubMed ID: 19736077
[TBL] [Abstract][Full Text] [Related]
17. Clinical and angiographic safety and efficacy trial with a new coronary stent: the RESTOR study of the R Stent.
den Heijer P; Rensing BJ; Foley DP; van den Bos AA; Corbeij HM; Quarles van Ufford MA; te Riele JA; Rooset PC; Serruys PW
J Invasive Cardiol; 2004 Aug; 16(8):402-5. PubMed ID: 15282413
[TBL] [Abstract][Full Text] [Related]
18. Unprotected left main bifurcation restenosis treated with a 2-stent technique.
Wainstein MV; Wainstein RV; Ribeiro JP
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E200-5. PubMed ID: 22972629
[TBL] [Abstract][Full Text] [Related]
19. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?
Jensen J; Lagerqvist B; Aasa M; Särev T; Nilsson T; Tornvall P
J Intern Med; 2006 Aug; 260(2):118-24. PubMed ID: 16882275
[TBL] [Abstract][Full Text] [Related]
20. Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique.
Colombo A; Mikhail GW; Michev I; Iakovou I; Airoldi F; Chieffo A; Rogacka R; Carlino M; Montorfano M; Sangiorgi GM; Corvaja N; Stankovic G
Catheter Cardiovasc Interv; 2005 Apr; 64(4):407-11; discussion 412. PubMed ID: 15789384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
